NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹1,697 Cr | ₹1,212 Cr | ₹849 Cr | ₹47 Cr | ₹299 Cr |
What is the latest Cash Flow from Operating Activities ratio of NATCO PHARMA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2025 | ₹1,697 Cr |
Mar2024 | ₹1,212 Cr |
Mar2023 | ₹849 Cr |
Mar2022 | ₹47 Cr |
Mar2021 | ₹299 Cr |
How is Cash Flow from Operating Activities of NATCO PHARMA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2025 | ₹1,697 Cr | 40.05 | |
Mar2024 | ₹1,212 Cr | 42.69 | |
Mar2023 | ₹849 Cr | 1,726.02 | |
Mar2022 | ₹47 Cr | -84.44 | |
Mar2021 | ₹299 Cr | - |
Compare Cash Flow from Operating Activities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹14,929.8 Cr | 3% | -5.7% | -40.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,140.0 Cr | 2.1% | 2.4% | -11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,290.0 Cr | 0.7% | 8.2% | 8.1% | Stock Analytics | |
CIPLA | ₹132,417.0 Cr | 5.6% | 3.9% | 1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,839.0 Cr | 1.5% | 0.1% | 1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,031.0 Cr | 3.7% | -3% | -6.4% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 3% |
-5.7% |
-40.9% |
SENSEX | 2.5% |
2% |
3.1% |
You may also like the below Video Courses